pharmaceutical industry

AstraZeneca Faces Long Haul Back to Health

GlaxoSmithKline Boss Says New Drugs Can Be Cheaper

Health Firms Demand Bills Overhaul from Spain to Stem Debt

Catalent Announces Major China Expansion

Chairman of China's Simcere Pharma Offers Buyout

Elan to Start Share Buyback Next Week

Schott Expands Footprint in "Pharmerging" Markets with Investment in Indonesia

Merck Veteran Named R&D Chief, After Drug Setbacks

Merck KGaA's Profit Up on Cost Cuts, Liquid Crystals

DSM Signs Master Supply Agreement with Eisai

Ashland to Expand Pharmaceutical Center of Excellence in Delaware

Pfizer Gets Celebrex Patent Extension

Par to Pay $45 Million, End US Probes Over AIDS Appetite Drug

Long-serving Roche Chairman to Step Down Next Year

Siegfried Reports Higher Sales and Profitability in FY 2012

Generics Brought Down Common Drug Prices in 2012

India Rules Against Bayer in Cancer Drug Patent Case

Hikma Eyes Options for Injectables Business

Canada's Valeant on Hunt for More Deals

Bayer 2013 Outlook Slightly Below Market View

Catalent Applied Drug Delivery Institute Appoints Executive Director

US Supreme Court Rules Against Amgen in Class Action

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

CordenPharma Expands with ICIG Acquisition of Farchemia

UCB in 2012: New Core Medicines Drive Growth

Switzerland's Roche Pledges to Open Up Access to Drug Data

FDA Halts Trials of Amgen Drug in Children, Cites Death

Dendreon Posts Smaller-than-expected Quarterly Loss

Royalty Pharma Proposes $6.6 Billion Bid for Elan

Hungary's Richter Forms Joint Venture in China

Affymax, Takeda Recall Anemia Drug Omontys After Deaths

Camelot Investigates Trends in the Global Pharmaceutical Industry

Almac, DSM Collaboration Agreement in Biocatalysis Continues with Success

Novartis Golden Handshake Angers Shareholders, Politicians

Anergis Expands Management Team

274 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

CONTINUUS Pharmaceuticals, Inc.

PureTech Systems

Arthur D. Little

Roland Berger GmbH

International Society for Pharmaceutical Engineering (ISPE)

Concept Heidelberg

PolarixPartner GmbH

Thomson Reuters

Bio Evaluation

trans-o-flex Express GmbH

Miebach Consulting GmbH

EquipNet Inc.

Dechema e.V.

Roche Group

Camelot Management Consultants AG

EvaluatePharma

VCI Verband Chem.- Ind. e.V

CPA Chemical Pharmac. Ass.

McKinsey & Company Inc.

CHEManager International c/o Wiley-VCH GmbH

ARC Advisory Group GmbH & Co KG

CHEManager c/o Wiley-VCH Verlag

Patheon Italia

Isomorphic Labs

Infraserv GmbH & Co. Höchst KG

Gilead Sciences, Inc.

The Scott Partnership

Novo Nordisk A/S

Fraunhofer SCS

BearingPoint GmbH

CatSci Ltd.

Siemens AG Industry Automation Division

Rotego Chem

WeylChem International GmbH

HAS Healthcare Advanced Synthesis SA

Camelot Management Consultants AG

LLamasoft Deutschland GmbH

Quotient Sciences